retatrutide phase 2 nejm 2023 weight loss percent 48 weeks (not yet approved in US but people using anyway) promises even potentially greater amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 Retatrutide vs Wegovy: which works

Description

Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a new type of hypoglycemic agent that has been shown to regulate blood glucose levels, reduce inflammatory responses and oxidative stress, and regulate lipid metabolism, among other effects

Retrieved 2008-05-19

doi: 10.1055/s-0042-101794

Someone with higher body fat may see more visible changes while someone already lean typically experiences subtle refinements better abdominal definition smoother transitions between muscle groups and reduced water retention

Wegovy Pill Clinical trials show that both versions of Wegovy can lead to comparable weight loss when combined with eating less and exercising more, says Fatima Cody Stanford, MD, MPH, an obesity medicine specialist at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School, both in Boston